UnitedHealth’s 2025 earnings guidance fell well short of Wall Street estimates, in the latest setback for the company.

Even while the Fed left its benchmark rate unchanged, many consumer rates have fluctuated over the first half of the year.

Pharma firms are calling for clarity on tariffs imposed under the new U.S.-EU trade agreement, as analysts warn that punitive ...